Journal of Cancer Research and Clinical Oncology

, Volume 129, Issue 12, pp 735–736 | Cite as

Expression of a novel lacrimal gland gene lacritin in human breast tissues

Rapid Communication

Abstract

Purpose

The purpose of this study was to examine breast tumors and normal breast tissues for the expression of the glycoprotein lacritin. The mRNA and protein expression of lacritin has been reported to be restricted to the lacrimal gland.

Methods

We investigated 37 human primary invasive breast tumors, seven breast cancer cell lines and 16 normal breast tissues by quantitative real-time PCR for lacritin expression.

Results

We detected lacritin transcipts in 51% (19/37) of the primary invasive breast tumors, in 71% (5/7) of the breast cancer cell lines, and also in 56% (9/16) of the normal breast tissues. No lacritin mRNA was detectable in peripheral blood of healthy individuals.

Conclusions

Here we show by quantitative real-time PCR that lacritin is expressed in human breast tumors, breast cancer cell lines, and normal breast. The previously reported restricted expression pattern of lacritin is therefore incorrect. Lacritin transcripts were not detected in peripheral blood which makes lacritin a potential candidate as a breast cancer marker gene.

Keywords

Lacritin expression Real-time PCR Breast cancer 

References

  1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (1983) RNA Synthesis and RNA processing. In: Molecular biology of the cell. Garland, New York, pp 406–429Google Scholar
  2. Bieche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R, Vidaud M (1999) Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res 59:2759–2765PubMedGoogle Scholar
  3. Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJHM, Pruntel R, Hart AAM, Rodenhuis S, van ‘t Veer LJ (2002) Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8:1871–1877PubMedGoogle Scholar
  4. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voute PA, Heisterkamp S, van Kampen A, Versteeg R (2001) The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 291:1289–1292Google Scholar
  5. Sanghi S, Kumar R, Lumsden A, Dickinson D, Klepeis V, Trinkaus-Randall V, Frierson HF Jr, Laurie GW (2001) cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland. J Mol Biol 310:127–139CrossRefPubMedGoogle Scholar
  6. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW (1995) Serial analysis of gene expression. Science 270:484–487Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • B. Weigelt
    • 1
  • A. J. Bosma
    • 1
  • L. J. van ‘t Veer
    • 1
    • 2
  1. 1.Division of Experimental TherapyThe Netherlands Cancer InstituteAmsterdamThe Netherlands
  2. 2.Department of PathologyThe Netherlands Cancer InstituteAmsterdamThe Netherlands

Personalised recommendations